Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Olopatadine Impurity 34

Olopatadine Impurity 34 is listed in the pharmaceutical impurity collection under CAS 875050-50-3. Its represented structure has formula C17H15IO4 and a calculated molecular weight of 410.21 g/mol.

2D chemical structure

O O O O I

Chemical identity

Catalog name
Olopatadine Impurity 34
Common name
Olopatadine Impurity 34
Chemical name
methyl 2-[4-[(2-formylphenyl)methoxy]-3-iodophenyl]acetate
CAS
875050-50-3
SMILES
COC(=O)Cc1ccc(OCc2ccccc2C=O)c(I)c1
InChI
InChI=1S/C17H15IO4/c1-21-17(20)9-12-6-7-16(15(18)8-12)22-11-14-5-3-2-4-13(14)10-19/h2-8,10H,9,11H2,1H3
InChIKey
MPYIWUWCXVMJCH-UHFFFAOYSA-N
Associated API
Olopatadine

Record ID: A3d458c3451ca

Computed properties

C17H15IO4 Molecular formula
410.207 g/molMolecular weight
410.0015 DaMonoisotopic exact mass
52.6 ŲTopological polar surface area
3.3982 Calculated LogP (Wildman–Crippen)
91.0405 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H I O 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight410.20771.67
Calculated LogP (Wildman–Crippen)3.398269.15
Topological polar surface area52.633.89
Hydrogen-bond acceptors450.68
Hydrogen-bond donors011.28
Rotatable bonds (strict)669.73

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC17H15IO4dimensionless
Molecular weight410.207g/mol
Monoisotopic exact mass410.0015Da
Topological polar surface area52.6Ų
Calculated LogP (Wildman–Crippen)3.3982dimensionless
Molar refractivity (Wildman–Crippen)91.0405cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors0count
Rotatable bonds (strict)6count
Heavy atoms22count
Heteroatoms5count
Rings2count
Aromatic rings2count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.1765fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area142.1252Ų
Valence electrons114count
Radical electrons0count
Bertz complexity682.1092index
Balaban J2.0703index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Olopatadine Impurity 34

Qualification and safety assessment of Olopatadine Impurity 34

Explore toxicological qualification of Olopatadine Impurity 34 and ICH M7 mutagenic impurity assessment of Olopatadine Impurity 34 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Olopatadine Impurity 34 and acceptable intake and limit justification for Olopatadine Impurity 34. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Olopatadine Impurity 34

Explore Altox services and software through the Altox Pharma-Hub.